Thyroid Eye Disease Program
Thyroid Eye Disease Program | The Infusion Centers at Catholic Health are now treating Thyroid Eye Disease (TED) with Tepezza (teprotumumab-trbw), a medication that works at the source to block IGF-1R, a key driver of TED pathophysiology throughout the course of the disease. By inhibiting IGF-1R, Tepezza produces quantifiable changes to the tissues behind the eye. As the largest enroller…
» Read More